Active ingredientLobaplatinCat. No. P-L077-001CAS 135558-11-1Family · Pharmaceutical analytical standards
Lobaplatin
A third-generation platinum anticancer drug, a relative of cisplatin, synthesised in Germany in 1990 and later approved in China, where it is used for small cell lung cancer, metastatic breast cancer and chronic myeloid leukaemia. This family brings together the active ingredient and other impurities.
Did you know?In its structure the platinum atom is bound to a lactate molecule, the same one that builds up in muscles during exercise: when it detaches in the body it releases the form that attacks the DNA of cancer cells.
Go to the active ingredient →Active ingredientLobaplatinCat. No. P-L077-001CAS 135558-11-1
ImpurityLobaplatin Impurity 1Cat. No. P-L077-002CAS 1240256-76-1
Impuritycis-1,2-Cyclobutanedimethanamine dihydrochlorideCat. No. P-L077-003CAS 206991-53-9
ImpurityLobaplatin Impurity 2 HydrochlorideCat. No. P-L077-013CAS 181486-56-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.